Human menopausal gonadotropins hMG Pergonal Metrodin

ovulation induction with is another option for the treatment of ovulatory dysfunction. Because of its expense and associated risk of multiple gestations, gonadotropin therapy should be reserved for patients who remain refractory to CC therapy. The pregnancy rate with gonadotropin therapy is 25% per cycle. This is most likely the result of recruitment of more follicles with gonadotropin therapy. The incidence of multiple gestations with gonadotropin therapy is 25% to 30%.

5. Luteal phase deficiency is treated with progesterone, usually prescribed as an intravaginal suppository at a dose of 25 mg twice a day until 8 to 10 weeks of gestation.

6. Women with ovulatory dysfunction secondary to ovarian failure or poor ovarian reserve should consider obtaining oocytes from a donor source.

Was this article helpful?

0 0

Post a comment